Current Surgical

Current Surgical is a United States-based startup founded in 2020 that aims to revolutionize the treatment of solid tumors with its precise tools. The company's slogan, "Precise tools for the treatment of solid tumors," encapsulates its core mission of automating surgical procedures, allowing doctors to focus on determining the best treatment for patients. This is facilitated by software-enabled surgical platform being developed, empowering doctors to precisely and micro-invasively treat a range of diseases. Recognized for its potential, Current Surgical has secured funding from notable venture capital firms such as True Ventures, 1517, and Scifounders, displaying strong support from the investment community. Additionally, the company has received backing from the National Science Foundation, underscoring the credibility of its technology. The latest investment, a non-equity assistance, took place on 03 August 2023 and was provided by The Long Beach Accelerator, signifying ongoing interest and financial support for Current Surgical's innovative approach to improving the accuracy and accessibility of surgery. As a player in the Health Care and Medical Devices industries and with the backing of influential investors, Current Surgical holds promise in driving advancements in surgical practices.